XML 98 R45.htm IDEA: XBRL DOCUMENT v3.24.0.1
GOODWILL AND INTANGIBLE ASSETS (Tables)
12 Months Ended
Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Reconciliation of Changes in the Company's Goodwill
A reconciliation of changes in the Company’s goodwill by reportable segment were as follows:
(in millions)Technologies & EquipmentConsumablesConnected Technology SolutionsEssential Dental SolutionsOrthodontic and Implant SolutionsWellspect HealthcareTotal
Balance at December 31, 2022
Goodwill5,902 866 $— $— $— $— $6,768 
Accumulated impairment losses(4,080)— — — — — (4,080)
Goodwill, net December 31, 2022$1,822 $866 $— $— $— $— $2,688 
Translation— — — — 13 
Balance at March 31, 2023
Goodwill$5,911 $870 $— $— $— $— $6,781 
Accumulated impairment losses(4,080)— — — — — (4,080)
Goodwill, net March 31, 2023$1,831 $870 $— $— $— $— $2,701 
Realignment of goodwill(1,831)(870)293 835 1,303 270 $— 
Translation— — — (5)
Goodwill, net June 30, 2023$— $— $293 $836 $1,298 $276 $2,703 
Impairment— — (291)— — — (291)
Translation— — (2)25 (1)26 
Balance at December 31, 2023
Goodwill$— $— $291 $840 $1,323 $275 $2,729 
Accumulated Impairment Losses— — (291)— — — (291)
Balance at December 31, 2023$— $— $— $840 $1,323 $275 $2,438 
Schedule of Identifiable Definite-Lived Intangible Assets
Identifiable definite-lived and indefinite-lived intangible assets at were as follows:
Year Ended December 31,
 20232022
(in millions) 
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Developed technology and patents$1,697 $(1,006)$691 $1,658 $(848)$810 
Tradenames and trademarks271 (102)169 273 (96)177 
Licensing agreements30 (27)30 (26)
Customer relationships1,070 (680)390 1,057 (600)457 
Total definite-lived$3,068 $(1,815)$1,253 $3,018 $(1,570)$1,448 
Indefinite-lived tradenames and trademarks447 — 447 450 — 450 
In-process R&D (a)
— — 
Total indefinite-lived452 — 452 455 — 455 
Total identifiable intangible assets$3,520 $(1,815)$1,705 $3,473 $(1,570)$1,903 
(a) Intangible assets acquired in a business combination that are in-process and used in R&D activities are considered indefinite-lived until the completion or abandonment of the R&D efforts. The useful life and amortization of those assets will be determined once the R&D efforts are completed.
Schedule of Indefinite-Lived Intangible Assets
Identifiable definite-lived and indefinite-lived intangible assets at were as follows:
Year Ended December 31,
 20232022
(in millions) 
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Developed technology and patents$1,697 $(1,006)$691 $1,658 $(848)$810 
Tradenames and trademarks271 (102)169 273 (96)177 
Licensing agreements30 (27)30 (26)
Customer relationships1,070 (680)390 1,057 (600)457 
Total definite-lived$3,068 $(1,815)$1,253 $3,018 $(1,570)$1,448 
Indefinite-lived tradenames and trademarks447 — 447 450 — 450 
In-process R&D (a)
— — 
Total indefinite-lived452 — 452 455 — 455 
Total identifiable intangible assets$3,520 $(1,815)$1,705 $3,473 $(1,570)$1,903 
(a) Intangible assets acquired in a business combination that are in-process and used in R&D activities are considered indefinite-lived until the completion or abandonment of the R&D efforts. The useful life and amortization of those assets will be determined once the R&D efforts are completed.